Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 79
Selected: 0
NCT IDTitle
NCT05320146A Sub Study of the Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH)
NCT06689254REVERSE: Improving Treatment-resistant Post Traumatic Stress Disorder (PTSD) with Glucocorticoid Receptor (GR) Antagonism
NCT06099769A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
NCT00130676A United States Study of Corlux for Psychotic Symptoms in Psychotic Major Depression
NCT00796783A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia
NCT06947304Evaluation of Miricorilant on Liver Fat in Patients With MASLD
NCT07276373Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies
NCT06108219A Phase 2b, Study Evaluating Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH)
NCT00569582A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome
NCT05772169Study to Determine the Prevalence of Hypercortisolism in Patients With Type 2 Diabetes and Treatment With Korlym® (Mifepristone) (CATALYST)
NCT02642939Study of Oral Mifepristone as Salvage Therapy in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer
NCT03259542Mifepristone Drug-Drug Interaction Study With CYP3A Inhibitor
NCT02762981Study to Evaluate Relacorilant (CORT125134) in Combination With Nab-paclitaxel in Participants With Solid Tumors
NCT03776812Study of Relacorilant in Combination With Nab-Paclitaxel for Patients With Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT03818256A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Miricorilant (CORT118335) in Obese Adults With Schizophrenia or Bipolar Disorder Treated With Antipsychotic Medications
NCT04795479T/QT Study to Investigate the Effect of Relacorilant on Cardiac Repolarization in Healthy Volunteers
NCT05407324Dazucorilant in Patients With Amyotrophic Lateral Sclerosis
NCT04249323Single and Multiple Ascending Dose Study of CORT113176 in Healthy Participants
NCT00698022A 4-week Study of Mifepristone in the Prevention of Risperidone-induced Weight Gain in Healthy Male Volunteers
NCT03512548Study in Healthy Subjects to Determine the Effect of an Inhibitor on Exposure to Relacorilant and Its Metabolites
NCT02663609Retrospective Chart Review Study of Korlym for the Treatment of ACTH Independent Cushing's Syndrome
NCT03379363Retrospective Chart Review Study of Pediatric Patients Treated With Korlym for Cushing Syndrome
NCT03878264Absolute Bioavailability and Metabolism Study of CORT118335 in Healthy Male Participants
NCT05553470Study to Evaluate the Effects of Hepatic Impairment on the Pharmacokinetics of Miricorilant
NCT04524403A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II)
NCT03604198Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome
NCT03067376A Study Designed to See How [14C]-CORT125134 is Taken up, Broken Down and Removed From the Body
NCT00936741An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome
NCT07240116Study Evaluating the Bioavailability of Miricorilant With Optional Food Effect Assessment in Healthy Adult Subjects
NCT04994743Safety, Tolerability, and Pharmacokinetic Study of CORT113176 in Healthy Participants
NCT00637494A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
NCT06829537Study of the Prevalence of Endogenous Hypercortisolism in Patients With Resistant Hypertension (MOMENTUM)
NCT05347979Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-glycoprotein Substrate Dabigatran Etexilate in Healthy Participants
NCT04672499Single and Multiple Dose Study of Miricorilant (CORT118335) Tablet Formulations in Healthy Participants
NCT05117489A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH)
NCT03457597Study in Healthy Subjects to Determine the Effect of Relacorilant on Exposure to Probe Substrates for Cytochrome P450s
NCT02804750Study to Evaluate CORT125134 in Participants With Cushing's Syndrome
NCT04990310Single Dose Absorption, Distribution, Metabolism, and Excretion Study of [14C]-CORT113176 in Healthy Male Participants
NCT02014337Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors
NCT02922257Biomarker Expression in Patients With ACTH-Dependent Cushing's Syndrome Before and After Surgery
NCT03442621Relacorilant Food Effect Study in Healthy Subjects
NCT00105105Mifepristone as Adjunctive Therapy in Alzheimer's Disease
NCT05712265Study to Evaluate the Effects of a Cytochrome P450 2C19 Inhibitor on the Pharmacokinetics of Miricorilant
NCT00208156A United States Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression
NCT04373265Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol)
NCT00752843A Phase I Study to Determine the Effect of Mifepristone on the Pharmacokinetics of Fluvastatin in Healthy Volunteers
NCT05217758RESET-medication Glucocorticoid Receptor (GR) Blockade As Disease Modifying Treatment for Depression with Childhood Trauma
NCT03540836A Study to Determine the Relative Bioavailability of Two New Relacorilant Capsule Variants
NCT00128505An International Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression
NCT03674814Study of Drug 1 (Enzalutamide) Plus Drug 2 (Relacorilant) for Patients With Prostate Cancer